Developmental outcomes in persistent pulmonary hypertension treated with nitric oxide therapy

Pediatrics International

Volumn 51, Issue 1, 2009, Pages 79-83

  Hosono, Shigeharu ^a,b   Ohno, Tutomu ^a   Kimoto, Hirofumi ^a   Shimizu, Masaki ^a   Takahashi, Shigeru ^b   Harada, Kensuke ^b  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hearing loss; Hypocapnea; Inhaled nitric oxide; Neurodevelopmental outcome; Permissive hypercapnea

Indexed keywords

CREATINE KINASE; NITRIC OXIDE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEVELOPMENTAL DISORDER; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING LOSS; HUMAN; HYPOCAPNIA; INFANT; NERVE CELL DIFFERENTIATION; OXYGENATION; PERSISTENT PULMONARY HYPERTENSION; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; RETROSPECTIVE STUDIES;

EID: 60849130734     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02664.x     Document Type: Article

References (32)

1. Kusuda S, Shishida N, Miyagi N, Hirabayashi M, Kim TJ. Cerebral blood flow during treatment for pulmonary hypertension. Arch. Dis. Child. Fetal Neonatal Ed. 1999 80 : F30 33.
2. Leavitt AM, Watchko JF, Bennett FC, Folsom RC. Neurodevelopmental outcome following persistent pulmonary hypertension of the neonate. J. Perinatol. 1987 11 288 91.
3. Sell EJ, Gaines JA, Gluckman C, Williams E. Persistent fetal circulation. Neurodevelopmental outcome. Am. J. Dis. Child. 1985 139 : 25 8.
4. Bifano EM, Pfannenstiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 1988 81 : 657 61.
5. Hendricks-Munoz KD, Walton JP. Hearing loss in infants with persistent fetal circulation. Pediatrics 1988 81 : 650 56.
6. Walton JP, Hendricks-Munoz K. Profile and stability of sensorineural hearing loss in persistent pulmonary hypertension of the newborn. J. Speech Hear. Res. 1991 34 : 1362 70.
7. Wung JT, James LS, Kilchevsky E, James E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 1985 76 : 488 94.
8. Marron MJ, Crisafi MA, Driscoll JM Jr. et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. Pediatrics 1992 90 : 392 6.
9. Clark RH, Kueser TJ, Walker MW et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N. Engl. J. Med. 2000 342 : 469 74.
10. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N. Engl. J. Med. 1997 336 : 597 604.
11. Roberts JD Jr., Fineman JR, Morin FC 3rd. et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N. Engl. J. Med. 1997 336 : 605 10.
12. Hosono S, Ohno T, Kimoto H et al. Inhaled nitric oxide therapy might reduce the need for hyperventilation therapy in infants with persistent pulmonary hypertension of the newborn. J. Perinat. Med. 2006 32 : 333 7.
13. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores. J. Pediatr. 2001 138 : 92 100.
14. Hosono S, Ohno T, Kimoto H et al. Follow-up study of auditory brainstem responses in infants with high unbound bilirubin levels treated with albumin infusion therapy. Pediatr. Int. 2002 44 : 488 92.
15. Gupta A, Rastogi S, Sahni R et al. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn: A single-center, 5-year experience. J. Perinatol. 2002 22 : 435 41.
16. Ellington M Jr., O'Reilly D, Allred EN et al. Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 2001 107 : 1351 6.
17. Fujikawa S, Yang L, Waffarn F, Lerner M. Persistent pulmonary hypertension of the newborn (PPHN) treated with inhaled nitric oxide: Preliminary hearing outcomes. J. Am. Acad. Audiol. 1997 8 : 263 8.
18. Ichiba H, Matsunami S, Itoh F et al. Three-year follow up of term and near-term infants treated with inhaled nitric oxide. Pediatr. Int. 2003 45 : 290 93.
19. Lipkin PH, Davidson D, Spivak L et al. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J. Pediatr. 2002 140 : 306 10.
20. Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N. Engl. J. Med. 2005 353 : 23 32.
21. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J. Pediatr. 2000 136 : 611 17.
22. Rosenberg AA, Kennaugh JM, Moreland SG et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J. Pediatr. 1997 131 : 70 75.
23. Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics 2005 115 : 1519 28.
24. Kawashiro N, Tsuchihashi N, Koga K, Kawano T, Itoh Y. Delayed post-neonatal intensive care unit hearing disturbance. Int. J. Pediatr. Otorhinolaryngol. 1996 34 : 35 43.
25. Lasky RE, Wiorek L, Becker TR. Hearing loss in survivors of neonatal extracorporeal membrane oxygenation (ECMO) therapy and high-frequency oscillatory (HFO) therapy. J. Am. Acad. Audiol. 1998 9 : 47 58.
26. Robertson CM, Tyebkhan JM, Peliowski A, Etches PC, Cheung PY. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr. 2006 95 : 214 23.
27. Salamy A, McKean CM. Postnatal development of human brainstem potentials during the first year of life. Electroencephalogr. Clin. Neurophysiol. 1976 40 : 418 26.
28. Starr A, Amlie RN, Martin WH, Sanders S. Development of auditory function in newborn infants revealed by auditory brainstem potentials. Pediatrics 1977 60 : 831 9.
29. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics 1998 102 : 1161 71.
30. Desai S, Kollros PR, Graziani LJ et al. Sensitivity and specificity of the neonatal brain-stem auditory evoked potential for hearing and language deficits in survivors of extracorporeal membrane oxygenation. J. Pediatr. 1997 131 : 233 9.
31. Hutchin ME, Gilmer C, Yarbrough WG. Delayed-onset sensorineural hearing loss in a 3-year-old survivor of persistent pulmonary hypertension of the newborn. Arch. Otolaryngol. Head Neck Surg. 2000 126 : 1014 17.
32. Hosono S, Imura S, Akiyama K et al. Effect of vibration on auditory organ systems in low-birth weight infants treated with high-frequency oscillatory ventilation: 5 year outcome. Pediatr. Int. 2001 43 : 16 19.